The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sorkina I.L.

Dermatovenerological Dispensary No 16

Sakaniia L.R.

Pervyĭ MGMU im. I.M. Sechenova

Troyanova S.Yu.

Research Clinical Center of Otorhinolaryngology of the Federal Medical and Biological Agency of the Russia, Moscow, Russia, 123182

Korsunskaia I.M.

Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences

Improving adherence to treatment in patients with rosacea

Authors:

Sorkina I.L., Sakaniia L.R., Troyanova S.Yu., Korsunskaia I.M.

More about the authors

Read: 1132 times


To cite this article:

Sorkina IL, Sakaniia LR, Troyanova SYu, Korsunskaia IM. Improving adherence to treatment in patients with rosacea. Russian Journal of Clinical Dermatology and Venereology. 2017;16(4):66‑71. (In Russ.)
https://doi.org/10.17116/klinderma201716466-70

Recommended articles:
Dissecting cellulitis of the scalp (Hoffman’s disease): a clinical case. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):45-48
Clinical and anamnestic features of rosa­cea in women in peri­menopausal period. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):49-55
Damage of human skin barrier components in expo­sure of Demo­dex specimens. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):219-226
Expe­rience of comprehensive treatment of erythematotelangiectatic rosa­cea. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):236-239
Angiopausin concentrate for skin prone to redness. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):369-374
Features of pero­xide-antioxidant imba­lance in patients with rosa­cea and approaches to comprehensive therapy. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):439-444
Adhe­rence of patients to acne therapy using systemic isotretinoin. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):483-488
Hardware technologies in rosa­cea treatment. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(6):814-821

References:

  1. Berg M, Liden S. An epidemiolodical study of rosacea. Acta Derm Venerol. 1989;69(5):419-442. https://doi.org/10.2340/00015555-0888
  2. Kimura Y, et al. Rosacea. Br J Pharmacol. 2006;148(6):860-870. https://doi.org/10.1111/j.1365-2125.2005.02511.x
  3. Davydova AV, Bakulev AL. The Study of personal characteristics of patients with rosacea. Saratov nauch.-med zhurn. 2014; 10(3):560-564. (In Russ.).
  4. Abokwidir M, Feldman SR. Systemic remedies include metronidazole, doxycycline, minocycline, clarithromycin and isotretinoin, while topical remedies are based on metronidazole 0.75%, azelaic acid 15 or 20%, sodium sulfacetamide, ivermectin 1%, permethrin 5%, and retinoid. Skin Appendage Disord. 2016 Sep;2(1-2):26-34. https://doi.org/10.1159/000446215
  5. Weinkle AP, Doktor V, et al. Update on the management of rosacea. Clin Cosmet Investig Dermatol. 2015;8:159-177. https://doi.org/10.2147/CCID.S58940
  6. Kennedy CC, Cantrell W, Elewski BE. Rosacea: a review of current topical, systemic and light-based therapies. G Ital Dermatol Venereol. 2009;144:673-688. https://doi.org/10.5275/ijcr.2010.11.01
  7. Park H, Del Rosso JQ. Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol. 2011;4:54-61. https://doi.org/10.1046/j.1525-1470.1998.1998015464.x
  8. Schaller M, Schöfer H, et al. State of the art: systemic rosacea management. J Dtsch Dermatol Ges. 2016 Dec;14:Suppl 6:29-37. https://doi.org/10.1111/ddg.13141
  9. Mantovani L, Zauli S, et al. Rosacea fulminans or acute rosacea? Report of 5 cases and review of the literature. G Ital Dermatol Venereol. 2016 Oct;151(5):553-557. https://doi.org/10.4103/0378-6323.132267
  10. Rademaker M. Very low-dose isotretinoin in mild to moderate papulopustular rosacea; a retrospective review of 52 patients. Australas J Dermatol. 2016 Jul 20. https://doi.org/10.1111/ajd.12522
  11. Sbidian E, Vicaut É, et al. A randomized-controlled trial of oral low-dose isotretinoin for difficult-to-treat papulopustular rosacea. J Invest Dermatol. 2016 Jun;136(6):1124-1129. https://doi.org/10.1016/j.jid.2016.01.025
  12. van Zuuren EJ, Fedorowicz Z, et al. Interventions for rosacea. Cochrane Database Syst Rev. 2015 Apr 28;(4):CD003262. https://doi.org/10.1002/14651858.CD003262.pub4
  13. Cantarutti N, Claps A, et al. Multi-drugs resistant acne rosacea in a child affected by Ataxia-Telangiectasia: successful treatment with Isotretinoin. Ital J Pediatr. 2015 Mar 28;41:23. https://doi.org/10.1186/s13052-015-0125-7
  14. Nickle SB, Peterson N, et al. Updated physician’s guide to the off-label uses of oral isotretinoin. J Clin Aesthet Dermatol. 2014 Apr;7(4):22-34. https://doi.org/10.1586/edm.10.58
  15. Erdogan FG, Yurtsever P, Aksoy D, Eskioglu F. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol. 1998;134(7):884-885. https://doi.org/10.1001/archderm.134.7.884
  16. Irvine C, Kumar P, Marks R. Isotretinoin in the treatment of rosacea and rhinophyma. In: Marks R, Plewig G, editors. Acne and Related Disorders: Proceedings of an International Symposium. London: Martin Dunitz. 1988;301-305. https://doi.org/10.1007/978-3-642-97234-8_80
  17. Jansen T, Plewig G, Kligman AM. Diagnosis and treatment of rosacea fulminans. Dermatology. 1994;188(4):251-254. Review. https://doi.org/10.1159/000247160
  18. Bostanci O, Borelli C, Schaller M. Treatment of extrafacial rosacea with low-dose isotretinoin. Acta Derm Venereol. 2010;90(4):409-410. https://doi.org/10.2340/00015555-0888
  19. Hoting E, Paul E, Plewig G. Treatment of rosacea with isotretinoin. Pharm Therap. 1986;25:660-663. https://doi.org/10.1111/j.1365-4362.1986.tb04533.x
  20. Dicken CH. Retinoids: a review. J Am Acad Dermatol. 1984;11:541-552. https://doi.org/10.1016/s0190-9622(84)70204-0
  21. abstract. Z Hautkr. 1985;60:120-124. https://doi.org/10.1007/978-3-642-99262-9_33
  22. Marsden JR, Shuster S, Neugebauer M. Response of rosacea to isotretinoin. Clin Exp Dermatol. 1984;9(5):484-488. https://doi.org/10.1111/j.1365-2230.1984.tb00842.x
  23. Gollnick H, Blume-Peytavi U, Szabó EL, et al. Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges. 2010;8(7):505-515. Epub 2010 Mar 12. https://doi.org/10.1111/j.1610-0387.2010.07345.x
  24. Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical retinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol. 1994;130(3):319-324. https://doi.org/10.1001/archderm.1994.01690030051008
  25. Hofer T. Continuous «microdose» isotretinoin in adult recalcitrant rosacea. Clin Exp Dermatol. 2004;29(2):204-205. https://doi.org/10.1111/j.1365-2230.2004.01472.x
  26. Uslu M, Savk E, Karaman G, Sendur N. Rosacea treatment with intermediate-dose isotretinoin: follow-up with erythema and sebum measurements. Acta Derm Venereol. 2012;92(1):73-77. https://doi.org/10.2340/00015555-1204
  27. Samcov AV, Gorbunov YuG. Isotretinoin in the treatment of rosacea. Vestn Dermatol Venerol. 2012;4:102-104. (In Russ.). https://doi.org/10.2340/00015555-0888
  28. Perlamutrov JuV et al. A comparative appraisal of the efficacy of different rosacea treatment methods. Vestn Dermatol Venerolю 2011;3:73-79. (In Russ.). https://doi.org/10.17116/klinderma201615695-101
  29. Sirmajs NS, Ustinov MV. The estimation of the efficacy of rosacea therapy using isotretinoin. Klin Dermatol Venerol. 2011;6:67-71. (In Russ.). https://doi.org/10.17116/klinderma201514620-27
  30. Gusoeva OV, Pharmacological analysis of the use of external dosage forms of metronidazole in experimental inflammation: Dis... kand. med.nauk. Kursk. 2009. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.